Infusion Therapy

FFL Partners Launches Sale Process for Apex Infusion

FFL Partners is seeking to sell ambulatory infusion therapy provider Apex Infusion, two sources tell Axios Pro. The PE-backed infusion market has been busy, but deal closes have been challenging as buyers become more selective. Read the full article: FFL Partners Launches Sale Process for Apex Infusion // Source: https://www.axios.com/pro/health-tech-deals/2026/04/07/ffl-sale-apex-infusion

FFL Partners Launches Sale Process for Apex Infusion Read More »

Opportunities in Home and Alternate Site Infusion, with Don Hooker

Home and alternate-site infusion therapy is a highly fragmented market. Just two large players command 35% to 40% market share while more than 800 smaller providers making up the remainder. And that fragmentation is exactly what’s drawing private equity interest. Don Hooker, director of research at Bourne Partners, a leading life science investment firm, joins

Opportunities in Home and Alternate Site Infusion, with Don Hooker Read More »

Dynamic Access Acquires PICC Stat in Minnesota

Dynamic Access, LLC announces the acquisition of PICC Stat, a respected, family-owned vascular access provider based in Minneapolis and recognized for its commitment to high-quality, patient-centered care. PICC Stat built a strong reputation through years of dependable service and strong support for the healthcare facilities it supported. Passed from father to son a few years

Dynamic Access Acquires PICC Stat in Minnesota Read More »

Health Systems’ Infusion Revenues Are Under Threat: What to Watch and How to Prepare

Infusion services make up a roughly $150 billion market in the U.S., and underpin the financial stability of major service lines, especially oncology. Historically, health systems have enjoyed strong volumes, favorable reimbursement, and access to 340B discounts that keep their infusion business profitable. But rising competition, payer and employer driven site of care shifts, and

Health Systems’ Infusion Revenues Are Under Threat: What to Watch and How to Prepare Read More »

Bain Capital Pulls Basic Home Infusion Process

Bain Capital is halting the sale process for its portfolio company Basic Home Infusion, two sources familiar tell Axios Pro. The decision comes as prospective infusion network buyers become more discerning on price. Read the full article: Bain Capital Pulls Basic Home Infusion Process // Source: https://www.axios.com/pro/health-tech-deals/2026/02/23/bain-capital-basic-home-infusion-auction

Bain Capital Pulls Basic Home Infusion Process Read More »

Scroll to Top